Long-term Impact of Cenobamate on Cognition in Patients with Drug-Resistant Focal Epilepsy: Outcomes from an Exploratory Real-World Study
In this exploratory, real-world study, we observed significant improvements in seizure frequency, concomitant ASM usage, and cognition at up to 18 months of cenobamate treatment in patients with drug-resistant focal epilepsy.
Authors
- Teresa Ramírez-García (ORCID: https://orcid.org/0009-0000-5207-1159)
- Yolanda López-Moreno (ORCID: https://orcid.org/0000-0003-2861-5915)
- Pedro Jesús Serrano-Castro (ORCID: https://orcid.org/0000-0002-3414-2707)
- Guillermina García Martín (ORCID: https://orcid.org/0000-0003-3894-9716)
- J. Parra (ORCID: https://orcid.org/0000-0002-4443-8931)
- Pablo Cabezudo‐García (ORCID: https://orcid.org/0000-0002-6421-5348)
- Alvaro Sanchez-Guijo
Institutions
- Hospital Regional Universitario de Málaga (ES)
- Andalusian Centre for Nanomedicine and Biotechnology (ES)
- Instituto de Investigación Biomédica de Málaga (ES)
- Universidad de Málaga (ES)
Publication Details
- Journal
- Neurology and Therapy
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1007/s40120-025-00859-y
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00